OBJECTIVE: This study compared the effects of alternate-day fasting (ADF) with those of daily calorie restriction (CR) on body weight and glucoregulatory factors in adults with overweight or obesity and insulin resistance. METHODS: This secondary analysis examined the data of insulin-resistant individuals (n = 43) who participated in a 12-month study that compared ADF (25% energy needs on "fast days"; 125% energy needs on alternating "feast days") with CR (75% energy needs every day) and a control group regimen. RESULTS: In insulin-resistant participants, weight loss was not different between ADF (-8% ± 2%) and CR (-6% ± 1%) by month 12, relative to controls (P < 0.0001). Fat mass and BMI decreased (P < 0.05) similarly from ADF and CR. ADF produced greater decreases (P < 0.05) in fasting insulin (-52% ± 9%) and insulin resistance (-53% ± 9%) compared with CR (-14% ± 9%; -17% ± 11%) and the control regimen by month 12. Lean mass, visceral fat mass, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, blood pressure, C-reactive protein, tumor necrosis factor α, and interleukin 6 values remained unchanged. CONCLUSIONS: These findings suggest that ADF may produce greater reductions in fasting insulin and insulin resistance compared with CR in insulin-resistant participants despite similar decreases in body weight.
OBJECTIVE: This study compared the effects of alternate-day fasting (ADF) with those of daily calorie restriction (CR) on body weight and glucoregulatory factors in adults with overweight or obesity and insulin resistance. METHODS: This secondary analysis examined the data of insulin-resistant individuals (n = 43) who participated in a 12-month study that compared ADF (25% energy needs on "fast days"; 125% energy needs on alternating "feast days") with CR (75% energy needs every day) and a control group regimen. RESULTS: In insulin-resistant participants, weight loss was not different between ADF (-8% ± 2%) and CR (-6% ± 1%) by month 12, relative to controls (P < 0.0001). Fat mass and BMI decreased (P < 0.05) similarly from ADF and CR. ADF produced greater decreases (P < 0.05) in fasting insulin (-52% ± 9%) and insulin resistance (-53% ± 9%) compared with CR (-14% ± 9%; -17% ± 11%) and the control regimen by month 12. Lean mass, visceral fat mass, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, blood pressure, C-reactive protein, tumor necrosis factor α, and interleukin 6 values remained unchanged. CONCLUSIONS: These findings suggest that ADF may produce greater reductions in fasting insulin and insulin resistance compared with CR in insulin-resistant participants despite similar decreases in body weight.
Authors: Eric Ravussin; Leanne M Redman; James Rochon; Sai Krupa Das; Luigi Fontana; William E Kraus; Sergei Romashkan; Donald A Williamson; Simin N Meydani; Dennis T Villareal; Steven R Smith; Richard I Stein; Tammy M Scott; Tiffany M Stewart; Edward Saltzman; Samuel Klein; Manju Bhapkar; Corby K Martin; Cheryl H Gilhooly; John O Holloszy; Evan C Hadley; Susan B Roberts Journal: J Gerontol A Biol Sci Med Sci Date: 2015-07-17 Impact factor: 6.053
Authors: Victoria A Catenacci; Zhaoxing Pan; Danielle Ostendorf; Sarah Brannon; Wendolyn S Gozansky; Mark P Mattson; Bronwen Martin; Paul S MacLean; Edward L Melanson; William Troy Donahoo Journal: Obesity (Silver Spring) Date: 2016-09 Impact factor: 5.002
Authors: C-S Kim; H-S Park; T Kawada; J-H Kim; D Lim; N E Hubbard; B-S Kwon; K L Erickson; R Yu Journal: Int J Obes (Lond) Date: 2006-03-14 Impact factor: 5.095
Authors: Luisa Torres; Joy L Lee; Seho Park; R Christian Di Lorenzo; Jonathan P Branam; Shelagh A Fraser; Benjamin A Salisbury Journal: JMIR Mhealth Uhealth Date: 2022-10-04 Impact factor: 4.947